Article
Linezolid resistance in clinical isolates of Staphylococcus aureus
12 Dec 2002
Abstract excerpt
Sir, Linezolid is the first oxazolidinone antibiotic to be licensed for treatment of Gram-positive infections. It is active against methicillin-resistant Staphylococcus aureus (MRSA), glycopeptide-intermediate S. aureus (GISA) and vancomycin-resistant enterococci (VRE).1 It inhibits the formation of the initiation complex formed with mRNA, fMet-tRNA and the 30S ribosomal subunit. Mutations to the central loop of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
